Glynux MV 3.3 Tablet is primarily used in the management of type 2 diabetes mellitus in adults. This medication is categorised under oral antidiabetic agents and comprises a combination of active ingredients that synergise to effectively control blood glucose levels.
• Management of type 2 diabetes mellitus
• Regulation of both fasting and postprandial blood glucose levels
• Reduction in the risk of cardiovascular disease in individuals with type 2 diabetes
• Prevention of diabetic complications such as neuropathy, nephropathy, and retinopathy
• Take Glynux MV 3.3 Tablet precisely as per your doctor’s instructions.
• Do not alter or exceed the prescribed dose without prior consultation with your doctor.
• Consult your doctor before ceasing the medication; do not discontinue without their guidance.
• Follow the dietary recommendations provided by your doctor.
Glynux MV 3.3 Tablet is taken orally.
The administration of Glynux MV 3.3 Tablet may lead to certain side effects, including:
• Nausea
• Vomiting
• Abdominal pain
• Diarrhoea
• Hypoglycaemia
Glynux MV 3.3 Tablet operates through the integrated action of its three active components:
• Glimepiride (3 mg): Classified under sulfonylureas, glimepiride facilitates insulin release by stimulating pancreatic beta-cell receptors, enhancing cellular glucose uptake, and decreasing hepatic glucose production.
• Metformin (500 mg): By activating AMP-kinase, metformin reduces hepatic glucose production, increases insulin sensitivity, and enhances peripheral glucose uptake while decreasing intestinal glucose absorption.
• Voglibose (0.3 mg): Voglibose inhibits alpha-glucosidase enzymes in the intestinal tract, delaying carbohydrate breakdown and absorption, thereby mitigating postprandial blood glucose surges.
It is contraindicated in pregnancy.
It is not recommended in breastfeeding women.
Not recommended as alcohol can increase the risk of hypoglycaemia and lactic acidosis.
Exercise caution when taking Glynux MV 3.3 Tablet if you have mild to moderate liver impairment. It is not recommended for patients with severe liver disease.
This medication is contraindicated in individuals with severe renal impairment or renal failure.
Due to the risk of hypoglycaemia, which may lead to confusion or tremors, caution is advised when driving or operating machinery.
Avoid using Glynux MV 3.3 Tablet if you have known allergies to glimepiride, metformin, voglibose, or any other ingredients in the formulation.
It is not recommended in children.
Elderly patients should take this medication under medical supervision due to increased susceptibility to side effects and potential liver and kidney issues.
Drug-Drug Interactions
• Corticosteroids: These medications may reduce the efficacy of Glynux MV 3.3 Tablet, thereby affecting blood glucose management.
• Diuretics: Certain diuretics can enhance the hypoglycaemic effect of this medicine, necessitating close monitoring.
• Calcium Channel Blockers: These agents may potentiate the glucose-lowering action of Glynux MV 3.3 Tablet.
• Cationic Medicines: Cationic agents can reduce metformin elimination, increasing the risk of its side effects.
Drug-Food Interactions
• Carbohydrates: Consuming large quantities of carbohydrates while on this medicine can induce significant blood glucose elevation.
Drug-Disease Interactions
• Heart Failure: Individuals with heart failure requiring pharmacological treatment should avoid this medication due to associated risks.
Daily Dosage
• Glynux MV 3.3 Tablet should be taken as prescribed by your doctor.
Missed Dose
• If a dose is missed, take it as soon as you remember. If it is nearly time for the next dose, skip the missed dose and resume your regular schedule. Do not double-dose to make up for a missed dose.
Overdose
• Symptoms of overdose may include nausea or stomach discomfort.
• Store Glynux MV 3.3 Tablet in a tightly sealed container at room temperature, ideally below 30°C.
• Protect the medication from light and moisture.
• Keep out of reach of children.
• Ensure usage before the expiry date indicated on the packaging.
• Maintain a balanced diet low in sugar to aid in blood glucose management.
• Engage in regular physical activity, such as walking or swimming, to improve insulin sensitivity and support overall diabetes management.
.avif)
%20(1).png)
.webp)